Back to Search Start Over

Eagle Pharmaceuticals awarded new US patent for BENDEKA running through to 2031

Source :
M2 Pharma. July 4, 2018
Publication Year :
2018

Abstract

M2 PHARMA-July 4, 2018-Eagle Pharmaceuticals awarded new US patent for BENDEKA running through to 2031 (C)2018 M2 COMMUNICATIONS Pharmaceutical company Eagle Pharmaceuticals Inc (Nasdaq:EGRX) revealed on Tuesday the receipt of [...]

Subjects

Subjects :
United States. Food and Drug Administration
Eagle Pharmaceuticals Inc. -- Intellectual property
Patents
Drug approval
Patent/copyright issue
Chemistry

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Pharma
Publication Type :
News
Accession number :
edsgcl.545295644

Tools

Authors Abstract Subjects Details